Verification in results-based financing (RBF) mechanisms is one of the key differentiators between it and related health financing structures such as social health insurance. Verifying that providers have achieved reported performance in RBF mechanisms is considered a crucial part of program...

Laboratories have historically been under supported in developing country health systems resulting in poor quality diagnosis and inadequate disease surveillance. Laboratory professionals are predominantly male with relatively limited female labor participation, with potential gender based...

XXX

Population growth, an unfinished agenda of communicable diseases and maternal health and nutrition, and the rapid rise of Non-communicable diseases are putting increasing strain on not just the Ministry of Health budget, but also the broader financial position of the government as a whole. These...

Universal Health Coverage is a powerful framework for a nation aiming to protect their population against health risks. However, countries face multiple challenges in implementing, achieving and sustaining UHC strategies. Sharing and learning from diverse country experiences may enable to foster...

While universal health coverage (UHC) offers a powerful goal for a nation, all countries-irrespective of income are struggling with achieving or sustaining UHC. France is a high-income country where HC is in effect universal. Health-related costs are covered by a mix of mandatory social health...

A consensus exists that rising income levels and technological development are among the key drivers of total health spending. However, determinants of public sector health expenditure are less well understood. This study examines a complex relationship across government health expenditure...

The aim of Health in All Policies (HiAP) is to bring diverse sectors together to find shared solutions; it focuses on identifying 'win-win' or 'cobenefits' such that policy measures contribute not only to improved health outcomes but also to outcomes desired by other sectors, such as education,...

India has a booming drug industry and has contributed to making generics at low prices worldwide. But medicines within India are overpriced and unaffordable. Price regulation of medicines is a key public policy measure for health of India’s teeming masses. Only the Government of India can...